{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:06:06Z","timestamp":1786575966490,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.mehy.2008.06.048","type":"journal-article","created":{"date-parts":[[2008,11,29]],"date-time":"2008-11-29T10:24:12Z","timestamp":1227954252000},"page":"333-337","source":"Crossref","is-referenced-by-count":86,"title":["Low-dose naltrexone for disease prevention and quality of life"],"prefix":"10.1016","volume":"72","author":[{"given":"Norman","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaak","family":"Panksepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2008.06.048_bib1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.npp.1301440","article-title":"Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects","volume":"33","author":"Weerts","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2008.06.048_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2210-6-3","article-title":"Pharmacological profiles of opioid ligands at kappa opioid receptors","volume":"6","author":"Gharagozlou","year":"2006","journal-title":"BMC Pharmacol"},{"key":"10.1016\/j.mehy.2008.06.048_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0196-9781(00)00233-3","article-title":"Nociceptin\/orphanin FQ and neurotransmitter release in the central nervous system","volume":"21","author":"Schlicker","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.mehy.2008.06.048_bib4","first-page":"281","article-title":"Naltrexone and other potential new pharmacological treatments of autism","volume":"4","author":"Panksepp","year":"1991","journal-title":"Brain Dysfunc"},{"key":"10.1016\/j.mehy.2008.06.048_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0165-1781(95)02601-R","article-title":"Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism, a double-blind, placebo-controlled study","volume":"58","author":"Bouvard","year":"1995","journal-title":"Psychiat Res"},{"key":"10.1016\/j.mehy.2008.06.048_bib6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jpain.2006.05.005","article-title":"Oxytrex minimizes physical dependence while providing effective analgesia, a randomized controlled trial in low back pain","volume":"7","author":"Webster","year":"2006","journal-title":"J Pain"},{"key":"10.1016\/j.mehy.2008.06.048_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/jcp.0b013e31814e5e9d","article-title":"Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence","volume":"27","author":"Mannelli","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.mehy.2008.06.048_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/apc.1995.9.3","article-title":"Efficacy of low dose naltrexone as an immune stabilizing agent for the treatment of HIV\/AIDS [letter]","volume":"9","author":"Bihari","year":"1995","journal-title":"AIDS Patient Care"},{"key":"10.1016\/j.mehy.2008.06.048_bib9","unstructured":"Bihari B, Drury FM, Ragone VP, Ottomanelli GA, Buimovici-Klein E, Orbe MG, et al. Low dose naltrexone in the treatment of Acquired Immune Deficiency Syndrome. In: Poster presentation at the IV international AIDS conference, Stockholm, Sweden; 1988."},{"key":"10.1016\/j.mehy.2008.06.048_bib10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.mehy.2004.09.024","article-title":"Low dose naltrexone therapy for multiple sclerosis","volume":"64","author":"Agrawal","year":"2005","journal-title":"Med Hyp"},{"key":"10.1016\/j.mehy.2008.06.048_bib11","unstructured":"<Lowdosenaltrexone@yahoogroups.com>."},{"key":"10.1016\/j.mehy.2008.06.048_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1572-0241.2007.01045.x","article-title":"Low-dose naltrexone therapy improves active Crohn\u2019s disease","volume":"102","author":"Smith","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.mehy.2008.06.048_bib13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/1352458508095828","article-title":"A Pilot Trial of Low Dose Naltrexone in Primary Progressive Multiple Sclerosis","volume":"14","author":"Gironi","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.mehy.2008.06.048_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-3565(25)20595-X","article-title":"Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation","volume":"232","author":"Tempel","year":"1985","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.mehy.2008.06.048_bib15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-3565(25)22983-4","article-title":"Antagonist-induced up-regulation of the putative epsilon opioid receptor in rat brain, comparison with kappa, mu and delta opioid receptors","volume":"255","author":"Giordano","year":"1990","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.mehy.2008.06.048_bib16","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/0024-3205(85)90322-4","article-title":"Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment","volume":"36","author":"Yoburn","year":"1985","journal-title":"Life Sci"},{"key":"10.1016\/j.mehy.2008.06.048_bib17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0091-3057(03)00166-7","article-title":"Chronic opioid antagonist treatment dose-dependently regulates mu-opioid receptors and trafficking proteins in vivo","volume":"75","author":"Rajashekara","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.mehy.2008.06.048_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0165-5728(97)00106-9","article-title":"Conditioned immunomodulation, investigations of the role of endogenous activity at mu, kappa, and delta opioid receptor subtypes","volume":"79","author":"Perez","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2008.06.048_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1365-2249.2003.02103.x","article-title":"Augmented production of proinflammatory cytokines and accelerated alltransplantation reactions in heroin-treated mice","volume":"132","author":"Holan","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.mehy.2008.06.048_bib20","first-page":"28","article-title":"Effects of endogenous and exogenous opioids on splenic natural killer cell activity","volume":"5","author":"Kraut","year":"1986","journal-title":"Nat Immun Cell Growth Regul"},{"key":"10.1016\/j.mehy.2008.06.048_bib21","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/sj.bjp.0701138","article-title":"Antinociceptive and immunosuppressive effects of opiate drugs, a structure-related activity study","volume":"121","author":"Sacerdote","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2008.06.048_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0006-8993(89)91562-X","article-title":"Opioid antagonist modulation of murine neuroblastoma, a profile of cell proliferation and opioid peptides and receptors","volume":"480","author":"Zagon","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2008.06.048_bib23","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/0024-3205(87)90711-9","article-title":"Modulation of human neuroblastoma transplanted into nude mice by endogenous opioid systems","volume":"41","author":"McLaughlin","year":"1987","journal-title":"Life Sci"},{"key":"10.1016\/j.mehy.2008.06.048_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0006-8993(82)90811-3","article-title":"Naltrexone-induced opiate receptor supersensitivity","volume":"245","author":"Zukin","year":"1982","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2008.06.048_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2249.1992.tb02971.x","article-title":"Decreased immunoreactive beta-endorphin in mononuclear leucocytes from patients with rheumatic diseases","volume":"87","author":"Wiedermann","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.mehy.2008.06.048_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00002508-200207000-00008","article-title":"Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression, preliminary report","volume":"18","author":"Panerai","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.mehy.2008.06.048_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/brbi.1994.1024","article-title":"Decreased beta-endorphin content in peripheral blood mononuclear leukocytes from patients with Crohn\u2019s disease","volume":"8","author":"Wiedermann","year":"1994","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.mehy.2008.06.048_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/jnnp.74.4.495","article-title":"Beta endorphin concentrations in PBMC of patients with different clinical phenotypes of multiple sclerosis","volume":"74","author":"Gironi","year":"2003","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"10.1016\/j.mehy.2008.06.048_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1468-2982.1992.1203155.x","article-title":"Beta-endorphin concentrations in the peripheral blood mononuclear cells of migraine and tension-type headache patients","volume":"12","author":"Leone","year":"1992","journal-title":"Cephalalgia"},{"key":"10.1016\/j.mehy.2008.06.048_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1468-2982.1993.1306413.x","article-title":"Beta-endorphin levels are reduced in peripheral blood mononuclear cells of cluster headache patients","volume":"13","author":"Leone","year":"1993","journal-title":"Cephalalgia"},{"issue":"Pt. 1","key":"10.1016\/j.mehy.2008.06.048_bib31","first-page":"743","article-title":"Mononuclear cell beta-endorphin concentration in women with and without endometriosis","volume":"79","author":"Vercellini","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.mehy.2008.06.048_bib32","first-page":"739","article-title":"Beta-endorphin prevents collagen induced arthritis by neuroimmuno-regulation pathway","volume":"26","author":"Yin","year":"2005","journal-title":"Neuro-Endocrinol Let"},{"key":"10.1016\/j.mehy.2008.06.048_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/0-306-47611-8_16","article-title":"Role of beta-endorphin in the modulation of immune responses, perspectives in autoimmune diseases","volume":"493","author":"Sacerdote","year":"2001","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.mehy.2008.06.048_bib34","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1749-6632.1987.tb35821.x","article-title":"Enkephalins and T-cell enhancement in normal volunteers and cancer patients","volume":"496","author":"Plotnikoff","year":"1987","journal-title":"Ann New York Acad Sci"},{"key":"10.1016\/j.mehy.2008.06.048_bib35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1126\/science.6867737","article-title":"Naltrexone modulates tumor response in mice with neuroblastoma","volume":"221","author":"Zagon","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.mehy.2008.06.048_bib36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0024-3205(84)90651-9","article-title":"Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma, a role for endogenous opioid systems in cancer","volume":"35","author":"Zagon","year":"1984","journal-title":"Life Sci"},{"key":"10.1016\/j.mehy.2008.06.048_bib37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-2999(85)90198-0","article-title":"beta-Funaltrexamine (beta-FNA] and neural tumor response in mice","volume":"116","author":"Zagon","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2008.06.048_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-8993(96)00740-8","article-title":"Activation of mu-opioid receptors are required for the conditioned enhancement of NK cell activity","volume":"737","author":"Hsueh","year":"1996","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.mehy.2008.06.048_bib39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/carcin\/12.4.637","article-title":"Facilitation of dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by restraint stress, role of beta-endorphin, prolactin and naltrexone","volume":"12","author":"Tejwani","year":"1991","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mehy.2008.06.048_bib40","first-page":"255","article-title":"A new neuroimmunotherapeutic strategy of subcutaneous low-dose interleukin-2 plus the long-acting opioid antagonist naltrexone in metastatic cancer patients progressing on interleukin-2 alone","volume":"23","author":"Lissoni","year":"2002","journal-title":"Neuroendocrinol Let"},{"key":"10.1016\/j.mehy.2008.06.048_bib41","first-page":"341","article-title":"Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone, modulation of interleukin-2-induced antitumor immunity by blocking the opioid system","volume":"23","author":"Lissoni","year":"2002","journal-title":"Neuroendocrinol Let"},{"key":"10.1016\/j.mehy.2008.06.048_bib42","first-page":"1053","article-title":"Opioid growth factor regulates the cell cycle of human neoplasias","volume":"17","author":"Zagon","year":"2000","journal-title":"Int J Oncol"},{"key":"10.1016\/j.mehy.2008.06.048_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3835(96)04119-5","article-title":"Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone","volume":"101","author":"Hytrek","year":"1996","journal-title":"Cancer Let"},{"key":"10.1016\/j.mehy.2008.06.048_bib44","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/1534735407306358","article-title":"Reversal of signs and symptoms of a B-cell lymphoma in a patient using only low-dose naltrexone","volume":"6","author":"Berkson","year":"2007","journal-title":"Integ Cancer Therap"},{"key":"10.1016\/j.mehy.2008.06.048_bib45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1534735405285901","article-title":"The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid\/low-dose naltrexone protocol","volume":"5","author":"Berkson","year":"2006","journal-title":"Integ Cancer Therap"},{"key":"10.1016\/j.mehy.2008.06.048_bib46","unstructured":"<www.Lowdosenaltrexone.org>, doctor-managed website."},{"key":"10.1016\/j.mehy.2008.06.048_bib47","first-page":"30","article-title":"Novel immunotherapeutic approaches to prostate cancer","volume":"7","author":"Dalgleish","year":"2005","journal-title":"Curr Opin Molec Therap"},{"key":"10.1016\/j.mehy.2008.06.048_bib48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0376-8716(01)00140-5","article-title":"Naltrexone potentiates anti-HIV-1 activity of antiretroviral drugs in CD4+ lymphocyte cultures","volume":"64","author":"Gekker","year":"2001","journal-title":"Drug Alc Depend"},{"key":"10.1016\/j.mehy.2008.06.048_bib49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4049\/jimmunol.173.1.42","article-title":"Opioid antagonist naltrexone disrupts feedback interaction between mu and delta opioid receptors in splenocytes to prevent alcohol inhibition of NK cell function","volume":"173","author":"Boyadjieva","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2008.06.048_bib50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2004.07.001","article-title":"Stress-induced modulation of NK activity during influenza viral infection, role of glucocorticoids and opioids","volume":"19","author":"Tseng","year":"2005","journal-title":"Brain Behav Immunol"},{"key":"10.1016\/j.mehy.2008.06.048_bib51","series-title":"Affective neuroscience","author":"Panksepp","year":"1998"},{"key":"10.1016\/j.mehy.2008.06.048_bib52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.brainresrev.2007.07.014","article-title":"Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective","volume":"56","author":"Alcaro","year":"2007","journal-title":"Brain Res Revs"},{"key":"10.1016\/j.mehy.2008.06.048_bib53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/13556210410001674130","article-title":"Naltrexone, report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature","volume":"9","author":"Brewer","year":"2004","journal-title":"Addict Biol"},{"key":"10.1016\/j.mehy.2008.06.048_bib54","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1469-8986.1992.tb02047.x","article-title":"Aerobic fitness and opioidergic inhibition of cardiovascular stress reactivity","volume":"29","author":"McCubbin","year":"1992","journal-title":"Psychophysiology"},{"key":"10.1016\/j.mehy.2008.06.048_bib55","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1037\/0022-006X.64.3.593","article-title":"Relaxation training and opioid inhibition of blood pressure response to stress","volume":"64","author":"McCubbin","year":"1996","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.mehy.2008.06.048_bib56","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0301-0511(95)05118-T","article-title":"The effects of running and meditation on beta-endorphin, corticotropin-releasing hormone and cortisol in plasma, and on mood","volume":"40","author":"Harte","year":"1995","journal-title":"Biol Psychol"},{"key":"10.1016\/j.mehy.2008.06.048_bib57","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pbb.2006.02.004","article-title":"Effect of opioid antagonism on conditioned place preferences to snack foods","volume":"83","author":"Jarosz","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.mehy.2008.06.048_bib58","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1017\/S1368980099000555","article-title":"The effects of nutrients on mood","volume":"3A","author":"Benton","year":"1999","journal-title":"Public Health Nutrit"},{"key":"10.1016\/j.mehy.2008.06.048_bib59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0031-9384(00)00411-X","article-title":"Tickling induces reward in adolescent rats","volume":"72","author":"Burgdorf","year":"2001","journal-title":"Physiol Behav"},{"key":"10.1016\/j.mehy.2008.06.048_bib60","first-page":"62","article-title":"Modulation of neuroimmune parameters during the eustress of humor-associated mirthful laughter","volume":"7","author":"Berk","year":"2001","journal-title":"Alt Therap Health Med"},{"key":"10.1016\/j.mehy.2008.06.048_bib61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0188-4409(01)00279-X","article-title":"Naltrexone-induced augmentation of sexual response in men","volume":"32","author":"Sathe","year":"2001","journal-title":"Arch Med Res"},{"key":"10.1016\/j.mehy.2008.06.048_bib62","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1090-0233(02)00237-X","article-title":"Neurophysiological correlates of affiliative behaviour between humans and dogs","volume":"165","author":"Odendaal","year":"2003","journal-title":"Vet J"},{"key":"10.1016\/j.mehy.2008.06.048_bib63","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/0163278702238051","article-title":"How the doctor\u2019s words affect the patient\u2019s brain","volume":"25","author":"Benedetti","year":"2002","journal-title":"Eval Health Profess"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987708005070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987708005070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T23:49:41Z","timestamp":1738712981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987708005070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0306987708005070"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2008.06.048","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}